Our mission is to be a trusted partner to our clients by delivering high quality, easily understood forecasts and valuations  that empower our clients to make powerful decisions to drive their business forward. We do this by hearing all voices, integrating market intelligence, transforming complex analytics into easily understood supportive evidence, delivering invaluable insights, and creating simple stories that galvanize ownership.

P3I, Our name is a constant reminder of how we partner with you to understand your product’s value


Jeff Olive

Jeff Olive, the founder of P3I Consulting, is a seasoned executive in the pharmaceutical industry with over 20 years of experience. With a proven track record in developing innovative analytics, deep insights, and strategic forecasts. He brings a wealth of experience, industry knowledge, and a proven ability to transform complexity into easily digested information for executive decision making. He is an expert in building industry-leading capabilities and teams. His leadership and collaborative stye have made significant contributions to shaping commercial strategy. 

Before founding P3I, Jeff held a pivotal role at EQRx, a groundbreaking biotech startup, where he served as a trusted partner to the CEO, CFO, and CCO as well as PD1 Strategy Extended and Portfolio Decision Teams he was invited to join. He provided invaluable market insights, competitive intelligence, forecasts and analytics to inform decisions related to launch sequencing, business development, pricing, and clinical strategy. 

Prior to his tenure at EQRx, Jeff led Merck’s establishment of its global oncology forecast capabilities and teams. His innovative methods played a pivotal role in delivering highly accurate forecasts for Keytruda - a $17+ billion franchise spanning numerous tumors and disease settings. Throughout his career, Jeff has demonstrated versatility and expertise in various functional areas, ranging from customer insights to scientific strategy, analytics, and payer contracts. Jeff is experienced in numerous therapeutic areas including immunology, diabetes, respiratory, and cardiovascular disease. 

Under Jeff’s leadership, you can trust in P3I Consulting to navigate the intricacies of the pharmaceutical landscape and chart the future.